MAPT and Alzheimer disease: One of the biomarkers of AD, the Tau protein, appears to induce the expression of at least some TEs (Guo et al., 2018), and the presence of TE products in the cytosol and endosomes induces neuroinflammation in AD patients (Evering et al., 2023).